Prevalence, incidence and future projection of diabetic eye disease in Europe: a systematic review and meta-analysis
The DOI matches its Crossref record; 79 of the 81 references it cites were found in a registry or an index.
Abstract
To examine the prevalence and incidence of diabetic eye disease (DED) among individuals with diabetes in Europe, a systematic review to identify all published European prevalence and incidence studies of DED in individuals with diabetes managed in primary health care was performed according to the MOOSE and PRISMA guidelines. The databases Medline, Embase and Web of Science were searched to 2 September 2017. Meta-analyses and meta-regressions were performed. The pooled prevalence estimates were applied to diabetes prevalence rates provided by the International Diabetes Foundation atlas and Eurostat population data, and extrapolated to the year 2050. Data of 35 prevalence and four incidence studies were meta-analyzed. Any diabetic retinopathy (DR) and diabetic macular edema (DME) were prevalent in 25.7% (95% CI 22.8-28.8%) and 3.7% (95% CI 2.2-6.2%), respectively. In meta-regression, the prevalence of DR in persons with type 1 diabetes was significantly higher compared to persons with type 2 diabetes (54.4% vs. 25.0%). The pooled mean annual incidence of any DR and DME in in persons with type 2 diabetes was 4.6% (95% CI 2.3-8.8%) and 0.4% (95% CI 0.5-1.4%), respectively. We estimated that persons with diabetes affected by any DED in Europe will increase from 6.4 million today to 8.6 million in 2050, of whom 30% require close monitoring and/or treatment. DED is estimated to be present in more than a quarter of persons with type 2 diabetes and half of persons with type 1 diabete…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The prognosis for retaining vision has improved dramatically over the past 40 years owing to improved metabolic and BP control.78,432,488–490”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [489]
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & the PRISMA Group* (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-4-200908180-00135 · Cited by 37,554
Quantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763
Dermyshi, E., Wang, Y., Yan, C., Hong, W., Qiu, G., Gong, X., & Zhang, T. (2017) · Neonatology · doi:10.1159/000454668 · Cited by 24,451
von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., Vandenbroucke, J. P., & Initiative, F. T. S. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040296 · Cited by 23,020
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
International Diabetes Federation 2017
Carracher, A. M., Marathe, P. H., & Close, K. L. (2018) · Journal of Diabetes · doi:10.1111/1753-0407.12644 · Cited by 13,418
Global prevalence and major risk factors of diabetic retinopathy
Yau, J. W. Y., Rogers, S. L., Kawasaki, R., Lamoureux, E. L., Kowalski, J. W., Bek, T., Chen, S.-J., Dekker, J. M., Fletcher, A., Grauslund, J., et al. (2012) · Diabetes Care · doi:10.2337/dc11-1909 · Cited by 4,985 · cited 4×
“The Meta-analysis for Eye Disease (META-EYE) study group has provided pooled global data on the prevalence and major risk factors of DR [3] and reported a prevalence of 34.”
BackgroundInfluentialWilkinson, C. P., Ferris, F. L., Klein, R. E., Lee, P. P., Agardh, C. D., Davis, M., Dills, D., Kampik, A., Pararajasegaram, R., & Verdaguer, J. T. (2003) · Ophthalmology · doi:10.1016/s0161-6420(03)00475-5 · Cited by 3,743
(1991) · Ophthalmology · doi:10.1016/s0161-6420(13)38012-9 · Cited by 2,048
Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss
Lee, R., Wong, T. Y., & Sabanayagam, C. (2015) · Eye and Vision · doi:10.1186/s40662-015-0026-2 · Cited by 1,569 · cited 1×
“DED affects almost 80% of persons with type 2 diabetes after 10 years of disease [4].”
BackgroundTHE COMPARISON OF PERCENTAGES IN MATCHED SAMPLES
COCHRAN, W. G. (1950) · Biometrika · doi:10.1093/biomet/37.3-4.256 · Cited by 1,465 · cited 1×
“Between-study heterogeneity was assessed with Higgins’ and Thompson’s I2 measure and tested by Cochran’s Q-test for heterogeneity [17, 18].”
MethodUnited Nations Statistics Division
(2006) · Choice Reviews Online · doi:10.5860/choice.43sup-0473 · Cited by 1,202
The Prevalence of Diabetic Retinopathy Among Adults in the United States
(2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.4.552 · Cited by 1,148 · cited 1×
“2% for sightthreatening diabetic retinopathy (STDR) were reported [71].”
BackgroundTing, D. S. W., Cheung, G. C. M., & Wong, T. Y. (2016) · Clinical & Experimental Ophthalmology · doi:10.1111/ceo.12696 · Cited by 1,066
Guidelines on Diabetic Eye Care
Wong, T. Y., Sun, J., Kawasaki, R., Ruamviboonsuk, P., Gupta, N., Lansingh, V. C., Maia, M., Mathenge, W., Moreker, S., Muqit, M. M. K., et al. (2018) · Ophthalmology · doi:10.1016/j.ophtha.2018.04.007 · Cited by 839
Diabetes mellitus and risk of pancreatic cancer: A meta-analysis of cohort studies
Ben, Q., Xu, M., Ning, X., Liu, J., Hong, S., Huang, W., Zhang, H., & Li, Z. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.03.003 · Cited by 685 · cited 1×
“We defined studies which included more than 80% of persons with type 2 diabetes but did not report results separately for type 1 and type 2 diabetes as type 2 diabetes studies, similarly to other metaanalyses of diseases relating to diabetes [20, 21].”
ResultSchmidt-Erfurth, U., Chong, V., Loewenstein, A., Larsen, M., Souied, E., Schlingemann, R., Eldem, B., Monés, J., Richard, G., & Bandello, F. (2014) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2014-305702 · Cited by 639 · cited 2×
“Noninvasive OCT scans are commonly used and strongly recommended in clinical practice for the diagnosis and follow-up of DME patients [74].”
BackgroundMethodDiabetes mellitus and risk of endometrial cancer: a meta-analysis
Friberg, E., Orsini, N., Mantzoros, C. S., & Wolk, A. (2007) · Diabetologia · doi:10.1007/s00125-007-0681-5 · Cited by 562 · cited 1×
“We defined studies which included more than 80% of persons with type 2 diabetes but did not report results separately for type 1 and type 2 diabetes as type 2 diabetes studies, similarly to other metaanalyses of diseases relating to diabetes [20, 21].”
ResultKohner, E. M. (1998) · Archives of Ophthalmology · doi:10.1001/archopht.116.3.297 · Cited by 474
Von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., & Vandenbroucke, J. P. (2008) · Gaceta Sanitaria · doi:10.1157/13119325 · Cited by 417
Bourne, R. R. A., Jonas, J. B., Bron, A. M., Cicinelli, M. V., Das, A., Flaxman, S. R., Friedman, D. S., Keeffe, J. E., Kempen, J. H., Leasher, J., et al. (2018) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2017-311258 · Cited by 349 · cited 2×
“Already today, the majority of cases of blindness and severe visual impairment in Europe is caused by retinal diseases such as AMD and DED [1, 2].”
BackgroundAn Alternative Method of Grading Diabetic Retinopathy
Klein, R., Klein, B. E. K., Magli, Y. L., Brothers, R. J., Meuer, S. M., Moss, S. E., & Davis, M. D. (1986) · Ophthalmology · doi:10.1016/s0161-6420(86)33606-6 · Cited by 308
Younis, N., Broadbent, D. M., Vora, J. P., & Harding, S. P. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12267-2 · Cited by 289
Prevalence of diabetic retinopathy within a national diabetic retinopathy screening service
Thomas, R. L., Dunstan, F. D., Luzio, S. D., Chowdhury, S. R., North, R. V., Hale, S. L., Gibbins, R. L., & Owens, D. R. (2015) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2013-304017 · Cited by 202
Grading and disease management in national screening for diabetic retinopathy in England and Wales
Harding, S., Greenwood, R., Aldington, S., Gibson, J., Owens, D., Taylor, R., Kohner, E., Scanlon, P., Leese, G., & Party, T. D. R. G. A. D. M. W. (2003) · Diabetic Medicine · doi:10.1111/j.1464-5491.2003.01077.x · Cited by 200
Diabetic Retinopathy and Cognitive Decline in Older People With Type 2 Diabetes
Ding, J., Strachan, M. W. J., Reynolds, R. M., Frier, B. M., Deary, I. J., Gerald, F. F. R., Lee, A. J., McKnight, J., Halpin, P., Swa, K., et al. (2010) · Diabetes · doi:10.2337/db10-0752 · Cited by 162
Jones, C. D., Greenwood, R. H., Misra, A., & Bachmann, M. O. (2012) · Diabetes Care · doi:10.2337/dc11-0943 · Cited by 150 · cited 2×
“Three studies presented data on the incidence of sight threatening DR (STDR) or referable DR (RDR) [46, 66, 68, 70].”
BackgroundThomas, R. L., Dunstan, F., Luzio, S. D., Roy Chowdury, S., Hale, S. L., North, R. V., Gibbins, R. L., & Owens, D. R. (2012) · BMJ · doi:10.1136/bmj.e874 · Cited by 142 · cited 3×
“Three studies presented data on the incidence of sight threatening DR (STDR) or referable DR (RDR) [46, 66, 68, 70].”
BackgroundA Protocol for Screening for Diabetic Retinopathy in Europe
Party, R. W. (1991) · Diabetic Medicine · doi:10.1111/j.1464-5491.1991.tb01583.x · Cited by 136
Pedro, R.-A., Ramon, S.-A., Marc, B.-B., Juan, F.-B., & Isabel, M.-M. (2010) · Ophthalmic Epidemiology · doi:10.3109/09286586.2010.498661 · Cited by 119
Incidence of Blindness and Severe Visual Impairment in Germany: Projections for 2030
Finger, R. P., Fimmers, R., Holz, F. G., & Scholl, H. P. N. (2011) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.10-6987 · Cited by 114 · cited 2×
“Already today, the majority of cases of blindness and severe visual impairment in Europe is caused by retinal diseases such as AMD and DED [1, 2].”
BackgroundSelf-citationDiabetic retinopathy management guidelines
Chakrabarti, R., Harper, C. A., & Keeffe, J. E. (2012) · Expert Review of Ophthalmology · doi:10.1586/eop.12.52 · Cited by 112 · cited 1×
“Several treatment guidelines recommend severe NPDR to be treated as well [63, 64].”
BackgroundIncidence of sight‐threatening retinopathy in Type 1 diabetes in a systematic screening programme
Younis, N., Broadbent, D. M., Harding, S. P., & Vora, J. P. (2003) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.01035.x · Cited by 103 · cited 2×
“Three studies presented data on the incidence of sight threatening DR (STDR) or referable DR (RDR) [46, 66, 68, 70].”
BackgroundValidation of self-reported diagnosis of diabetes in the 1946 British birth cohort
Pastorino, S., Richards, M., Hardy, R., Abington, J., Wills, A., Kuh, D., & Pierce, M. (2015) · Primary Care Diabetes · doi:10.1016/j.pcd.2014.05.003 · Cited by 92
Four-Year Incidence of Diabetic Retinopathy in a Spanish Cohort: The MADIABETES Study
Salinero-Fort, M. Á., Andrés-Rebollo, F. J. S., de Burgos‐Lunar, C., Arrieta-Blanco, F. J., Gómez‐Campelo, P., & on behalf of MADIABETES Group (2013) · PLoS ONE · doi:10.1371/journal.pone.0076417 · Cited by 83 · cited 1×
“Of those, all studies reported incidence of any DR and two studies reported incidence of clinically significant DME [68, 69].”
BackgroundPrevalence of diabetic eye disease in an inner city population: The liverpool diabetic eye study
Broadbent, D., Scott, J. A., Vora, J. P., & Harding, S. P. (1999) · Eye · doi:10.1038/eye.1999.43 · Cited by 82
Raum, P., Lamparter, J., Ponto, K. A., Pető, T., Höhn, R., Schulz, A., Schneider, A., Wild, P. S., Pfeiffer, N., & Mirshahi, A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0127188 · Cited by 82
Prevalence of diabetic retinopathy in children and adolescents with IDDM
Kernell, A., Dedorsson, I., Johansson, B., WICKSTRÖM, C. P., Ludvigsson, J., Tuvemo, T., Neiderud, J., Sjöström, K., Malmgren, K., Kanulf, P., et al. (1997) · Diabetologia · doi:10.1007/s001250050679 · Cited by 82
Younis, N., Broadbent, D., Harding, S. P., & Vora, J. P. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.2002.00854.x · Cited by 78
Cost-effectiveness of Different Diabetic Retinopathy Screening Modalities
Pasquel, F. J., Hendrick, A. M., Ryan, M. E., Cason, E., Ali, M. K., & Narayan, K. M. V. (2015) · Journal of Diabetes Science and Technology · doi:10.1177/1932296815624109 · Cited by 74 · cited 1×
“As showcased by the UK, implementing national DED screening translates to decreasing visual loss baused by DED but comes at a considerable cost [75].”
BackgroundDiabetic retinopathy and socioeconomic deprivation in Gloucestershire
Scanlon, P. H., Carter, S. C., Foy, C., Husband, R. F. A., Abbas, J., & Bachmann, M. O. (2008) · Journal of Medical Screening · doi:10.1258/jms.2008.008013 · Cited by 70
The prevalence of retinopathy in subjects with and without type 2 diabetes mellitus
Ólafsdóttir, E., Andersson, D. K. G., Dedorsson, I., & Stefánsson, E. (2013) · Acta Ophthalmologica · doi:10.1111/aos.12095 · Cited by 68
Giuffrè, G., Lodato, G., & Dardanoni, G. (2004) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-004-0880-4 · Cited by 66 · cited 1×
“Only one Italian study relied on self-reported diagnoses of diabetes only [30].”
BackgroundTromsø eye study: prevalence and risk factors of diabetic retinopathy
Bertelsen, G., Pető, T., Lindekleiv, H., Schirmer, H., Solbu, M. D., Toft, I., Sjølie, A. K., & Njølstad, I. (2012) · Acta Ophthalmologica · doi:10.1111/j.1755-3768.2012.02542.x · Cited by 59
Ponto, K. A., Koenig, J., Pető, T., Lamparter, J., Raum, P., Wild, P. S., Lackner, K. J., Pfeiffer, N., & Mirshahi, A. (2016) · Diabetologia · doi:10.1007/s00125-016-4013-5 · Cited by 58 · cited 1×
“Two studies reported a prevalence of DED in undiagnosed DM: The Gutenberg Health Study (GHS) and the Diabetes Audit and Research in Tayside Scotland study (DARTS) [45, 65].”
BackgroundChanges observed in diabetic retinopathy: eight-year follow-up of a Spanish population
Romero-Aroca, P., de la Riva-Fernandez, S., Valls-Mateu, A., Sagarra-Alamo, R., Moreno-Ribas, A., & Soler, N. (2016) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2015-307689 · Cited by 55 · cited 3×
“Three studies presented data on the incidence of sight threatening DR (STDR) or referable DR (RDR) [46, 66, 68, 70].”
BackgroundLing, R., Ramsewak, V., Taylor, D., & Jacob, J. (2002) · Eye · doi:10.1038/sj/eye/6700081 · Cited by 52
Prevalence of diabetic retinopathy and eye care in a rural area of Spain
López, M. I., Díez, A., Velilla, S., Rueda, A., Alvarez, A., & Pastor, J. C. (2002) · Ophthalmic Epidemiology · doi:10.1076/opep.9.3.205.1516 · Cited by 49
Massin, P., Angioï-Duprez, K., Bacin, F., Villatte-cathelineau, B., Cathelineau, G., Chaine, G., COSCAS, G. J., Flament, J., Sahel, J., Turut, P., et al. (1996) · PubMed · Cited by 49
Gunnlaugsdottir, E., Halldorsdottir, S., Klein, R., Eiriksdottir, G., Klein, B. E., Benediktsson, R., Harris, T. B., Launer, L. J., Aspelund, T., Gudnason, V., et al. (2012) · Diabetologia · doi:10.1007/s00125-011-2395-y · Cited by 47
Dutra-Medeiros, M., Mesquita, E. M., Papoila, A. L., Genro, V., & Raposo, J. F. (2015) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2015-306727 · Cited by 43
Schulze-Döbold, C., Erginay, A., Robert, N., Chabouis, A., & Massin, P. (2012) · Diabetes & Metabolism · doi:10.1016/j.diabet.2012.05.003 · Cited by 40
Cribado de retinopatía diabética y teleoftalmología
Rubio, M. M., Moya, M. M., Bernabé, A. B., & Martínez, J. B. (2012) · Archivos de la Sociedad Española de Oftalmología · doi:10.1016/j.oftal.2012.04.004 · Cited by 38
Leese, G. P., Morris, A. D., Swaminathan, K., Petrie, J. R., Sinharay, R., Ellingford, A., Taylor, A., Jung, R. T., Newton, R. W., & Ellis, J. D. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01603.x · Cited by 38
Prevalence of Retinal Vein Occlusion in Europe: A Systematic Review and Meta-Analysis
Li, J. Q., Terheyden, J. H., Welchowski, T., Schmid, M. C., Letow, J., Wolpers, A. C., Holz, F. G., & Finger, R. P. (2018) · Ophthalmologica · doi:10.1159/000494224 · Cited by 31 · cited 1×
“To assess risk of bias and quality of primary studies or systematic reviews identified from database searches, fulltexts of eligible publications were examined using a previously described checklist [13].”
MethodSelf-citationRomero‐Aroca, P., Fernandez-Ballart, J. D., Baget-Bernaldiz, M., Méndez-Marín, I., & Salvat-Serra, M. (2007) · Archivos de la Sociedad Española de Oftalmología · doi:10.4321/s0365-66912007000400005 · Cited by 30
Diabetes and diabetic retinopathy in people aged 50 years and older in Hungary
Tóth, G., Szabó, D., Sándor, G. L., Szalai, I., Lukács, R., Pék, A., Tóth, G. Z., Papp, A., Nagy, Z. Z., Limburg, H., et al. (2016) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2016-309016 · Cited by 30
Prevalence of diabetic retinopathy in Norway: report from a screening study
Kilstad, H. N., Sjølie, A. K., Gøransson, L. G., Hapnes, R., Henschien, H. J., Alsbirk, K. E., Fossen, K., Bertelsen, G., Holstad, G., & Bergrem, H. (2011) · Acta Ophthalmologica · doi:10.1111/j.1755-3768.2011.02160.x · Cited by 27
Patients' knowledge of their chronic disease - the influence of socio-demographic characteristics.
Hocking, A., Laurence, C., & Lorimer, M. F. (2013) · PubMed · Cited by 26
Vleming, E. N., Castro, M., López-Molina, M. I., & Teus, M. A. (2009) · Archivos de la Sociedad Española de Oftalmología · doi:10.4321/s0365-66912009000500003 · Cited by 23
Diabetic retinopathy screening and teleophthalmology
Rubio, M. M., Moya, M. M., Bernabé, A. B., & Martínez, J. B. (2012) · Archivos de la Sociedad Española de Oftalmología (English Edition) · doi:10.1016/j.oftale.2012.04.016 · Cited by 23
Dépistage de larétinopathie diabétique en Bourgogne par un rétinographe non mydriatique itinérant
Soulié-Strougar, M., Charles, A., Métral, P., Quercia, P., Souchier, M., Chirpaz, L., Bron, A. M., & Creuzot-Garcher, C. P. (2007) · Journal Français d Ophtalmologie · doi:10.1016/s0181-5512(07)89560-x · Cited by 22
Ellis, J. D., Zvandasara, T., Leese, G., McAlpine, R., MacEwen, C. J., Baines, P. S., Crombie, I. K., & Morris, A. D. (2010) · British Journal of Ophthalmology · doi:10.1136/bjo.2010.196204 · Cited by 20 · cited 1×
“Two studies reported a prevalence of DED in undiagnosed DM: The Gutenberg Health Study (GHS) and the Diabetes Audit and Research in Tayside Scotland study (DARTS) [45, 65].”
BackgroundRetinopathy in diabetic patients aged 15-50 years in the county of Umeå, Sweden
Larsson, L., Alm, A., Bergenheim, T. A., Lithner, F., & Bergström, R. (1999) · Acta Ophthalmologica Scandinavica · doi:10.1034/j.1600-0420.1999.770415.x · Cited by 19
Diabetic eye complications in a medium sized municipality in southwest Norway
Hapnes, R., & Bergrem, H. (1996) · Acta Ophthalmologica Scandinavica · doi:10.1111/j.1600-0420.1996.tb00607.x · Cited by 19
Bueso, E. S., Fernández‐Vigo, J. I., Pérez, C. F., Merino, A. M., & Perianes, J. F. (2005) · Archivos de la Sociedad Española de Oftalmología · doi:10.4321/s0365-66912005000300010 · Cited by 18
Maicas, C. T., Fernández‐Real, J. M., Ricart, W., Ferrer, R. V., & Prats, M. V. (2005) · Archivos de la Sociedad Española de Oftalmología · doi:10.4321/s0365-66912005000200006 · Cited by 15
A protocol for screening for diabetic retinopathy in Europe. Retinopathy Working Party.
(1991) · PubMed · Cited by 15
Dépistage de la rétinopathie diabétique par télédiagnostic dans le Haut-Rhin
Lenoble, P., Kheliouen, M., Bourderont, D., Klinger, V., Nasica, X., Benseddik, Y., & Holl, P. (2009) · Journal Français d Ophtalmologie · doi:10.1016/j.jfo.2009.01.006 · Cited by 13
Kuiv, R., Tein, P., Algvere, P. V., Bäcklund, L. B., & Holm, O. C. (1997) · Acta Ophthalmologica Scandinavica · doi:10.1111/j.1600-0420.1997.tb00412.x · Cited by 9
Santos-Bueso, E., Fernández, C., Macarro, A., & Fernández‐Vigo, J. I. (2007) · Archivos de la Sociedad Española de Oftalmología · doi:10.4321/s0365-66912007000300007 · Cited by 8
Prevalencia de retinopatía diabética en Extremadura
Carrasco, M. M. G. (1995) · Dialnet (Universidad de la Rioja) · Cited by 5
I. über spontane Heilung von Netzhautgliom
Meller, J. (1923) · Ophthalmologica · doi:10.1159/000294945 · Cited by 3
Zietz, B., Kasparbauer, A., Ottmann, S., Spiegel, D. P., & Palitzsch, K. D. (2008) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/s-2007-1024518 · Cited by 3
Prevalencia de retinopatía diabética en el Centro de Salud de Torrejoncillo (Cáceres)
Bueso, E. S., Merino, A., Garrote, T., López, J. F., & de Oftalmología, C. (2002) · Cited by 3
Research works printed but not linked: 7
- Schwarzer G. Meta: an R package for meta-analysis. R News. 2007;7:40–5.
- Gil Hernández MA, Abreu Reyes P, Pareja Rios A, Martinez Piñero A. Estudio de la retinopatía diabética en la población de la isla de Hierro. Arch Soc Canar Oftal. 2000;11:23–6.
- Bueso E, Fernandez-Vigo J, Perez C, Merino A, Perianes J. Prevalence of diabetic retinopathy in the Regional Community of Extremadura. 1997–2001 (Extremadura Project to Prevent Blindness). Arch Soc Esp Oftalmol. 2005;80:187–94.
- Santos-Bueso E, Fernandez-Perez C, Macarro A, Fernandez-Vigo J. Prevalence of diabetic retinopathy in the city of Badajoz 2002 (Extremadura project to prevent blindness). Arch Soc Esp Oftalmol. 2007;82:153–8.
- Teruel MC, Fernandez-Real JM, Ricart W, Valent FR, Valles PM. Prevalence of diabetic retinopathy in the region of Girona. Study of related factors. Arch Soc Esp Oftalmol. 2005;80:85–91.
- Diabetic Retinopathy Study Research Group. Report No. 7: a modification of the Airlie House classification of diabetic retinopathy. Investig Ophthalmol Vis Sci. 1981;21:210–26.
- Facey K, Cummins E, Macpherson K, Morris A, Reay L, Slattery J. Health technology assessment report 1: organisations of services for diabetic retinopathy screening. Glasgow: Health Technology Board for Scotland; 2002.
Cited by
Screening for diabetic retinopathy: new perspectives and challenges
Vujosevic, S., Aldington, S. J., Silva, P., Hernández, C., Scanlon, P., Peto, T., & Simó, R. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30411-5 · Cited by 671
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Im, J. H. B., Jin, Y.-P., Chow, R., & Yan, P. (2022) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2022.01.009 · Cited by 148
Recent Advances in Age-Related Macular Degeneration Therapies
Fabre, M., Mateo, L., Lamaa, D., Baillif, S., Pagès, G., Demange, L., Ronco, C., & Benhida, R. (2022) · Molecules · doi:10.3390/molecules27165089 · Cited by 111
Liu, R., Li, L., Shao, C., Cai, H., & Wang, Z. (2022) · Journal of Diabetes Research · doi:10.1155/2022/1531289 · Cited by 100
“…on future predictions show that the incidence of diabetes in Europe is expected to increase by 2 million people over the next 30 years; approximately 50% of patients with type 1 diabetes and approximately 25% of patients with type 2 diabetes will continue to su ff er from diabetic eye disease [81].”
Background
Metadata
- Authors
- Li, J. Q., Welchowski, T., Schmid, M., Letow, J., Wolpers, C., Pascual-Camps, I., Holz, F. G., & Finger, R. P.
- Affiliations
- University of Bonn (DE)
- Hospital Universitari i Politècnic La Fe (ES)
- Corresponding author
- Finger, Robert P.
- ORCID
- Venue
- European Journal of Epidemiology
- Published
- 2019-09-12
- Volume
- 35
- Issue
- 1
- Pages
- 11-23
- ISSN
- 0393-2990 (ISSN-L)
- 1573-7284
- OpenAlex
- W2972391601
- Cited by
- 179
- References
- 81
- Citations by year
- 2026: 18 · 2025: 23 · 2024: 29 · 2023: 31 · 2022: 39 · 2021: 28 · 2020: 11
- FWCI
- 3.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- European Journal of Epidemiology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- European Society of Retina Specialists
- Jackstaedt Stiftung
- Else Kröner-Fresenius-Stiftung
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Retinal Imaging and Analysis
- Keywords
- diabetic eye disease, diabetic retinopathy, diabetic macular edema, prevalence, incidence, type 1 diabetes, type 2 diabetes, future projections, primary care, health planning, Europe
- MeSH terms
- Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Diabetic Retinopathy, Europe, Female, Humans, Macular Edema, Male, Risk Factors, Incidence, Prevalence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.